Cataloging the interactome of small molecules and the human proteome

Drug Development Research

Volumn 72, Issue 1, 2011, Pages 1-3

  Gurwitz, David ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Drug proteome interactome; In silico drug design; National Center for Biotechnology Information; Natural compounds; PubChem; Small molecules

Indexed keywords

PROTEOME;

BIOASSAY; COMPUTER MODEL; DRUG DESIGN; DRUG PROTEIN BINDING; HUMAN; MEDICAL LITERATURE; MOLECULAR INTERACTION; NATIONAL HEALTH ORGANIZATION; REVIEW;

EID: 79951794612     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20396     Document Type: Review

References (11)

1. De Las Rivas J, Fontanillo C. 2010. Protein-protein interactions essentials: key concepts to building and analyzing interactome networks. PLoS Comput Biol 6:e1000807.
2. Grant MA. 2011. Integrating computational protein function prediction into drug discovery initiatives. Drug Dev Res 72:4-16 (this issue).
3. Huang H, Chen Q, Ku X, Meng L, Lin L, Wang X, Zhu C, Wang Y, Chen Z, Li M, Jiang H, Chen K, Ding J, Liu H. 2010. A series of alpha-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity. J Med Chem 53:3048-3064.
4. Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, Hufeisen SJ, Jensen NH, Kuijer MB, Matos RC, Tran TB, Whaley R, Glennon RA, Hert J, Thomas KL, Edwards DD, Shoichet BK, Roth BL. 2009. Predicting new molecular targets for known drugs. Nature 462:175-181.
5. Kozikowski AP, Cho SJ, Jensen NH, Allen JA, Svennebring AM, Roth BL. 2010. HTS and rational drug design to generate a class of 5-HT2C-selective ligands for possible use in schizophrenia. Chem Med Chem 5:1221-1225.
6. Liu JJ, Zeng HN, Zhang LR, Zhan YY, Chen Y, Wang Y, Wang J, Xiang SH, Liu WJ, Wang WJ, Chen HZ, Shen YM, Su WJ, Huang PQ, Zhang HK, Wu Q. 2010. A unique pharmacophore for activation of the nuclear orphan receptor Nur77 in vivo and in vitro. Cancer Res 70:3628-3637.
7. Murphy EA, Shields DJ, Stoletov K, Dneprovskaia E, McElroy M, Greenberg JI, Lindquist J, Acevedo LM, Anand S, Majeti BK, Tsigelny I, Saldanha A, Walsh B, Hoffman RM, Bouvet M, Klemke RL, Vogt PK, Arnold L, Wrasidlo W, Cheresh DA. 2010. Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes the inactive state of PDGFRbeta/B-RAF. Proc Natl Acad Sci USA 2;107:4299-4304.
8. Scherzer-Attali R, Pellarin R, Convertino M, Frydman-Marom A, Egoz-Matia N, Peled S, Levy-Sakin M, Shalev DE, Caflisch A, Gazit E, Segal D. 2010. Complete phenotypic recovery of an Alzheimer's disease model by a quinone-tryptophan hybrid aggregation inhibitor. PLoS One 5:e11101.
9. Schuffenhauer A, Zimmermann J, Stoop R, van der Vyver JJ, Lecchini S, Jacoby E. 2002. An ontology for pharmaceutical ligands and its application for in silico screening and library design. J Chem Inf Comput Sci 42:947-955. (Pubitemid 35355244)
10. Takahashi T, Ohta K, Mihara H. 2010. Rational design of amyloid beta peptide-binding proteins: pseudo-Abeta beta-sheet surface presented in green fluorescent protein binds tightly and preferentially to structured Abeta. Proteins 78:336-347.
11. Wang Y, Xiao J, Suzek TO, Zhang J, Wang J, Bryant SH. 2009. PubChem: a public information system for analyzing bioactivities of small molecules. 2009. Nucleic Acids Res 37:W623-W633.